+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Drug Screening Market Research Report by Product & Service, Sample Type, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2023
  • Region: United States
  • 360iResearch™
  • ID: 5721701
The United States Drug Screening Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Drug Screening Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Drug Screening Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Drug Screening Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Drug Screening Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Drug Screening Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Drug Screening Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product & Service, the market is studied across Drug Screening Products and Drug Screening Services. The Drug Screening Products is is further studied across Analytical Instruments, Assay Kits, Calibrators & Controls, Consumables, Rapid Testing Devices, and Sample Collection Tubes. The Analytical Instruments is is further studied across Breathalyzers, Chromatography Instruments, and Immunoassay Analyzers. The Breathalyzers is is further studied across Fuel-Cell Breathalyzers and Semiconductor Breathalyzers. The Rapid Testing Devices is is further studied across Oral Fluid Testing Devices and Urine Testing Devices. The Urine Testing Devices is is further studied across Dip Cards, Drug Testing Cassettes, and Drug Testing Cups.
  • Based on Sample Type, the market is studied across Breath Samples, Hair Samples, Oral Fluid Samples, and Urine Samples.
  • Based on End User, the market is studied across Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Individual Users, Pain Management Centers, Schools & Colleges, and Workplaces.
  • Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Drug Screening Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Drug Screening Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Drug Screening Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Drug Screening Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Drug Screening Market, including Abbott Laboratories, Alfa Scientific Designs, American Bio Medica Corporation, Bio-Rad Laboratories, Inc., D.tec International Ltd, Danaher Corporation, Drägerwerk AG & Co. KGaA, F. Hoffmann-La Roche Ltd, Innovative Testing Solutions, Laboratory Corporation of America Holdings, Mayo Clinic Laboratories, Omega Laboratories, Inc., Quest Diagnostics, Securetec Detektions-Systeme AG, Shimadzu Scientific Instruments., Siemens Healthineers AG, Thermo Fisher Scientific, Inc., and United States Drug Testing Laboratories, Inc..

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Drug Screening Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Drug Screening Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Drug Screening Market?
4. What is the competitive strategic window for opportunities in the United States Drug Screening Market?
5. What are the technology trends and regulatory frameworks in the United States Drug Screening Market?
6. What is the market share of the leading vendors in the United States Drug Screening Market?
7. What modes and strategic moves are considered suitable for entering the United States Drug Screening Market?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Huge investments made to support drug discovery projects
5.1.1.2. Increasing rate of geriatric population and chronic disorders
5.1.2. Restraints
5.1.2.1. Threat of manipulation of the drug screening process and results
5.1.3. Opportunities
5.1.3.1. Technological advancements made to improve the accuracy of drug screening methods
5.1.3.2. Development of novel equipment and kits for advanced drug screening
5.1.4. Challenges
5.1.4.1. Stringent regulations and standards set by the FDA for drug screening equipment
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Drug Screening Market, by Product & Service
6.1. Introduction
6.2. Drug Screening Products
6.3.1. Analytical Instruments
6.3.2.1. Breathalyzers
6.3.2.2.1. Fuel-Cell Breathalyzers
6.3.2.2.2. Semiconductor Breathalyzers
6.3.2.2. Chromatography Instruments
6.3.2.3. Immunoassay Analyzers
6.3.2. Assay Kits
6.3.3. Calibrators & Controls
6.3.4. Consumables
6.3.5. Rapid Testing Devices
6.3.6.1. Oral Fluid Testing Devices
6.3.6.2. Urine Testing Devices
6.3.6.3.1. Dip Cards
6.3.6.3.2. Drug Testing Cassettes
6.3.6.3.3. Drug Testing Cups
6.3.6. Sample Collection Tubes
6.3. Drug Screening Services

7. Drug Screening Market, by Sample Type
7.1. Introduction
7.2. Breath Samples
7.3. Hair Samples
7.4. Oral Fluid Samples
7.5. Urine Samples

8. Drug Screening Market, by End User
8.1. Introduction
8.2. Criminal Justice Systems & Law Enforcement Agencies
8.3. Drug Testing Laboratories
8.4. Drug Treatment Centers
8.5. Hospitals
8.6. Individual Users
8.7. Pain Management Centers
8.8. Schools & Colleges
8.9. Workplaces

9. California Drug Screening Market
9.1. Introduction

10. Florida Drug Screening Market
10.1. Introduction

11. Illinois Drug Screening Market
11.1. Introduction

12. New York Drug Screening Market
12.1. Introduction

13. Ohio Drug Screening Market
13.1. Introduction

14. Pennsylvania Drug Screening Market
14.1. Introduction

15. Texas Drug Screening Market
15.1. Introduction

16. Competitive Landscape
16.1. FPNV Positioning Matrix
16.1.1. Quadrants
16.1.2. Business Strategy
16.1.3. Product Satisfaction
16.2. Market Ranking Analysis, By Key Player
16.3. Market Share Analysis, By Key Player
16.4. Product Portfolio Analysis, By Key Player
16.5. Competitive Scenario
16.5.1. Merger & Acquisition
16.5.2. Agreement, Collaboration, & Partnership
16.5.3. New Product Launch & Enhancement
16.5.4. Investment & Funding
16.5.5. Award, Recognition, & Expansion

17. Company Usability Profiles
17.1. Abbott Laboratories
17.2. Alfa Scientific Designs
17.3. American Bio Medica Corporation
17.4. Bio-Rad Laboratories, Inc.
17.5. D.tec International Ltd
17.6. Danaher Corporation
17.7. Drägerwerk AG & Co. KGaA
17.8. F. Hoffmann-La Roche Ltd
17.9. Innovative Testing Solutions
17.10. Laboratory Corporation of America Holdings
17.11. Mayo Clinic Laboratories
17.12. Omega Laboratories, Inc.
17.13. Quest Diagnostics
17.14. Securetec Detektions-Systeme AG
17.15. Shimadzu Scientific Instruments.
17.16. Siemens Healthineers AG
17.17. Thermo Fisher Scientific, Inc.
17.18. United States Drug Testing Laboratories, Inc.

18. Appendix
18.1. Discussion Guide
18.2. License & Pricing

List of Figures
FIGURE 1. UNITED STATES DRUG SCREENING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES DRUG SCREENING MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES DRUG SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES DRUG SCREENING MARKET DYNAMICS
FIGURE 8. UNITED STATES DRUG SCREENING MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES DRUG SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT & SERVICE, 2030
FIGURE 12. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
FIGURE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, 2018-2030 (USD MILLION)
FIGURE 16. UNITED STATES DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, 2018-2030 (USD MILLION)
FIGURE 17. UNITED STATES DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES DRUG SCREENING MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, 2018-2030 (USD MILLION)
FIGURE 21. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 22. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
FIGURE 23. UNITED STATES DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES DRUG SCREENING MARKET SIZE, BY DIP CARDS, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, 2018-2030 (USD MILLION)
FIGURE 29. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING SERVICES, 2018-2030 (USD MILLION)
FIGURE 30. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2030 (%)
FIGURE 31. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 32. UNITED STATES DRUG SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY SAMPLE TYPE, 2030
FIGURE 33. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, 2018-2030 (USD MILLION)
FIGURE 34. UNITED STATES DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, 2018-2030 (USD MILLION)
FIGURE 35. UNITED STATES DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, 2018-2030 (USD MILLION)
FIGURE 36. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, 2018-2030 (USD MILLION)
FIGURE 37. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 38. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 39. UNITED STATES DRUG SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 40. UNITED STATES DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, 2018-2030 (USD MILLION)
FIGURE 41. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, 2018-2030 (USD MILLION)
FIGURE 42. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, 2018-2030 (USD MILLION)
FIGURE 43. UNITED STATES DRUG SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 44. UNITED STATES DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, 2018-2030 (USD MILLION)
FIGURE 45. UNITED STATES DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, 2018-2030 (USD MILLION)
FIGURE 46. UNITED STATES DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, 2018-2030 (USD MILLION)
FIGURE 47. UNITED STATES DRUG SCREENING MARKET SIZE, BY WORKPLACES, 2018-2030 (USD MILLION)
FIGURE 48. CALIFORNIA DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 49. FLORIDA DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 50. ILLINOIS DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 51. NEW YORK DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 52. OHIO DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 53. PENNSYLVANIA DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 54. TEXAS DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 55. UNITED STATES DRUG SCREENING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 56. UNITED STATES DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 57. UNITED STATES DRUG SCREENING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022


List of Tables
TABLE 1. UNITED STATES DRUG SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES DRUG SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING PRODUCTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES DRUG SCREENING MARKET SIZE, BY ANALYTICAL INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATHALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES DRUG SCREENING MARKET SIZE, BY FUEL-CELL BREATHALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES DRUG SCREENING MARKET SIZE, BY SEMICONDUCTOR BREATHALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES DRUG SCREENING MARKET SIZE, BY CHROMATOGRAPHY INSTRUMENTS, BY STATE, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES DRUG SCREENING MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES DRUG SCREENING MARKET SIZE, BY ASSAY KITS, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES DRUG SCREENING MARKET SIZE, BY ASSAY KITS, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES DRUG SCREENING MARKET SIZE, BY CALIBRATORS & CONTROLS, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES DRUG SCREENING MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES DRUG SCREENING MARKET SIZE, BY RAPID TESTING DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES DRUG SCREENING MARKET SIZE, BY ORAL FLUID TESTING DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE TESTING DEVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES DRUG SCREENING MARKET SIZE, BY DIP CARDS, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES DRUG SCREENING MARKET SIZE, BY DIP CARDS, BY STATE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING CASSETTES, BY STATE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING CUPS, BY STATE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE COLLECTION TUBES, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING SERVICES, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG SCREENING SERVICES, BY STATE, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES DRUG SCREENING MARKET SIZE, BY BREATH SAMPLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. UNITED STATES DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, 2018-2030 (USD MILLION)
TABLE 46. UNITED STATES DRUG SCREENING MARKET SIZE, BY HAIR SAMPLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 47. UNITED STATES DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES DRUG SCREENING MARKET SIZE, BY ORAL FLUID SAMPLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES DRUG SCREENING MARKET SIZE, BY URINE SAMPLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES DRUG SCREENING MARKET SIZE, BY CRIMINAL JUSTICE SYSTEMS & LAW ENFORCEMENT AGENCIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TESTING LABORATORIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES DRUG SCREENING MARKET SIZE, BY DRUG TREATMENT CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES DRUG SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES DRUG SCREENING MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES DRUG SCREENING MARKET SIZE, BY INDIVIDUAL USERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES DRUG SCREENING MARKET SIZE, BY PAIN MANAGEMENT CENTERS, BY STATE, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES DRUG SCREENING MARKET SIZE, BY SCHOOLS & COLLEGES, BY STATE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES DRUG SCREENING MARKET SIZE, BY WORKPLACES, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES DRUG SCREENING MARKET SIZE, BY WORKPLACES, BY STATE, 2018-2030 (USD MILLION)
TABLE 68. CALIFORNIA DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 69. CALIFORNIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 70. CALIFORNIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 71. CALIFORNIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. FLORIDA DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 73. FLORIDA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 74. FLORIDA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 75. FLORIDA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 76. ILLINOIS DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 77. ILLINOIS DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 78. ILLINOIS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 79. ILLINOIS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. NEW YORK DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 81. NEW YORK DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 82. NEW YORK DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 83. NEW YORK DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. OHIO DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 85. OHIO DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 86. OHIO DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 87. OHIO DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. PENNSYLVANIA DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 89. PENNSYLVANIA DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 90. PENNSYLVANIA DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 91. PENNSYLVANIA DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 92. TEXAS DRUG SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 93. TEXAS DRUG SCREENING MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
TABLE 94. TEXAS DRUG SCREENING MARKET SIZE, BY SAMPLE TYPE, 2018-2030 (USD MILLION)
TABLE 95. TEXAS DRUG SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. UNITED STATES DRUG SCREENING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 97. UNITED STATES DRUG SCREENING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 98. UNITED STATES DRUG SCREENING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 99. UNITED STATES DRUG SCREENING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 100. UNITED STATES DRUG SCREENING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 101. UNITED STATES DRUG SCREENING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 102. UNITED STATES DRUG SCREENING MARKET MERGER & ACQUISITION
TABLE 103. UNITED STATES DRUG SCREENING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 104. UNITED STATES DRUG SCREENING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 105. UNITED STATES DRUG SCREENING MARKET INVESTMENT & FUNDING
TABLE 106. UNITED STATES DRUG SCREENING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 107. UNITED STATES DRUG SCREENING MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Alfa Scientific Designs
  • American Bio Medica Corporation
  • Bio-Rad Laboratories, Inc.
  • D.tec International Ltd
  • Danaher Corporation
  • Drägerwerk AG & Co. KGaA
  • F. Hoffmann-La Roche Ltd
  • Innovative Testing Solutions
  • Laboratory Corporation of America Holdings
  • Mayo Clinic Laboratories
  • Omega Laboratories, Inc.
  • Quest Diagnostics
  • Securetec Detektions-Systeme AG
  • Shimadzu Scientific Instruments.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific, Inc.
  • United States Drug Testing Laboratories, Inc.

Methodology

Loading
LOADING...